痰热清对脑出血后肺部感染的辅助治疗作用

目的：探讨痰热清注射液辅助头孢哌酮舒巴坦治疗脑出血患者肺部感染的有效性及安全性。方法：将82例脑出血合并肺部感染患者随机分为痰热清组、对照组,两组均给予头孢哌酮舒巴坦静滴,痰热清组加用痰热清注射液静滴,观察痰热清组、对照组治疗脑出血患者肺部感染的临床效果和不良反应。结果：痰热清组总有效率为88.10%,对照组总有效率为72.50%,两组总有效率相比,差异具有显著性;痰热清组患者治疗后的体温开始下降、咳嗽开始缓解时间较对照组快,差异具有显著性;痰热清组、对照组对半身不遂、口眼歪斜、言语謇涩或不语、偏身麻木等症状的治疗作用差异无统计学意义。痰热清组、对照组均未发现明显的毒副作用,未见二重感染等不良反应发生。结论：痰热清注射液辅助头孢哌酮舒巴坦治疗脑出血患者肺部感染安全,能增加头孢哌酮舒巴坦治疗肺部感染的疗效。

THE ADJUNCT TREATMENT EFFECT OF TANREQING INJECTION ON PULMONARY INFECTION OF INTRACEREBRAL HEMORRHAGE

Objective： To observe the safety and effect of Tanreqing injection combined with cefoperazone and sulbactam on pulmonary infection in patients with intracerebral hemorrhage.Methods： Eighty-two patients with pulmonary infection of intracerebral hemorrhage were randomly divided into Tanreqing group and control group.The Tanreqing group was treated by Tanreging combined with cefoperazone and sulbactam.The clinical effect and side effect of the two groups were observed.Results：The total effective rate was 88.10% in Tanreqing group,superior to those of the control group（72.50%）.The time of temperature decreasing and cough reducing in Tanreqing group were obviously quicker than those of the control group.There were no side effects and superinfection in Tanreqing group and control group.Conclusion：Tanreqing injection combined with cefoperazone and sulbactam is safe in pulmonary infection in patients with intracerebral hemorrhage and can increase the effect of cefoperazone and sulbactam.